🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "focused steps to address cost of living issues" in the upcoming Budget.

During an interview with the BBC, she emphasized that curbing inflation is a joint task of both the government and the Bank of England.

The UK's inflation rate is expected to be the highest among the G7 industrialized countries this calendar year and the following year.

Potential Utility Bill Interventions

Reports indicate the administration could intervene to bring down energy bills, such as by slashing the present 5% rate of VAT applied on energy.

A further possibility is to reduce some of the policy costs currently included in bills.

Budgetary Constraints and Analyst Expectations

The government will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for these actions.

The view from most experts is that Reeves will have to announce higher taxes or budget cuts in order to meet her voluntary borrowing rules.

Earlier on the same day, calculations indicated there was a twenty-two billion pound gap for the Treasury chief to address, which is at the lower end of expectations.

"It is a joint task between the central bank and the administration to bear down further on some of the sources of price increases," Reeves informed the BBC in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Tax Pledges and International Concerns

While much of the focus has been on likely tax increases, the Treasury chief said the latest information from the fiscal watchdog had not altered her commitment to manifesto promises not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with growing international and trade tensions for the fiscal tax moves, probably to be focused on those "most able to pay."

Global Economic Disputes

Commenting on worries about the UK's commercial links with the Asian nation she said: "Our national security invariably take priority."

Last week's declaration by China to increase trade restrictions on rare earths and other materials that are crucial for advanced tech production led American leader Donald Trump to threaten an extra 100% tariff on goods from the Asian country, increasing the risk of an full-scale commercial conflict between the two largest economies.

The American finance chief labeled China's move "commercial pressure" and "a international production control attempt."

Asked about considering the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "harmful for the world economy and creates further headwinds."

"It is my opinion there are fields where we should challenge China, but there are also important prospects to trade with China's economy, including financial services and other sectors of the economy. We've got to get that equilibrium correct."

The chancellor also confirmed she was cooperating with international partners "regarding our own essential resources plan, so that we are more independent."

NHS Medicine Pricing and Funding

Reeves also recognized that the cost the NHS spends on pharmaceuticals could go up as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning operations in the UK, with several attributing the modest returns they are getting.

Recently, the government science advisor said the cost the NHS spends on medicines would have to rise to halt firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor stated to media: "It has been observed due to the payment system, that drug testing, recent pharmaceuticals have not been offered in the United Kingdom in the extent that they are in other European countries."

"The objective is to guarantee that individuals getting treatment from the NHS are can obtain the best critical drugs in the globe. And so we are reviewing these issues, and... aiming to attract more capital into Britain."